Methadone Clinics in cities of New Jersey
- Atlantic City
- Barrington
- Belvidere
- Brick
- Bridgeton
- Camden
- Cape May Court House
- Cliffwood
- Denville
- East Orange
- Elizabeth
- Hamilton Square
- Irvington
- Jersey City
- Kearny
- Marlboro
- Merchantville
- Middlesex
- Mt. Holly
- Neptune City
- New Brunswick
- Newark
- Newton
- Paramus
- Passaic
- Paterson
- Pennsauken
- Perth Amboy
- Phillipsburg
- Plainfield
- Randolph
- Red Bank
- Seabrook
- Secaucus
- Somerdale
- Somers Point
- Somerville
- South Amboy
- South Toms River
- Toms River
- Trenton
- Vineland
Medication Treatment for Opioid Use Disorder Across New Jersey
New Jersey treats opioid use disorder (OUD) as a medical condition, and all three FDA-approved medications are available statewide: methadone, buprenorphine (including Suboxone), and naltrexone (including the monthly Vivitrol injection). The state pairs a dense corridor of opioid treatment programs (OTPs) and office-based prescribers across North Jersey and the Philadelphia-adjacent south with telehealth that reaches the more rural northwest and the Pinelands, where the nearest clinic can be a county away.
The listings on this page connect you to providers near you. If you are not sure where to start, call the helpline on this page or a clinic directly.
Your Treatment Options and the Two Settings That Offer Them
Three medications are approved for opioid use disorder. Understanding how each is dispensed tells you what the listings on this page represent.
Methadone for OUD is provided only through a licensed opioid treatment program, not a regular pharmacy, and is taken under a program’s supervision until you become eligible for take-home doses.
Buprenorphine, which includes Suboxone and other buprenorphine-naloxone products as well as the extended-release injectable Sublocade, works differently. Any clinician with a standard DEA registration can prescribe it in an office, and you fill it at a pharmacy, though OTPs offer it too.
Naltrexone, including Vivitrol, is not a controlled substance, and any licensed provider can prescribe it. However, treatment starts only after you have been off opioids for a set period, so a clinician times it carefully.
An opioid treatment program is the clinic model, with on-site dosing and counseling and a path to take-homes. Office-based opioid treatment (OBOT) means seeing a doctor, nurse practitioner, or physician assistant who prescribes buprenorphine or naltrexone you pick up yourself.
New Jersey invested heavily in the office-based route, which is why a person can now start buprenorphine in a primary care office in much of the state.
Neither setting is the “right” one for everyone. That is a decision to make with a clinician based on the medication that fits your life.
To understand how a daily-dosing program differs from office care, see how a methadone clinic works day to day.
State Rules, Medicaid Coverage, and How New Jersey Funds Treatment
New Jersey’s Medicaid program, NJ FamilyCare, covers all three medications for opioid use disorder. Most beneficiaries receive care through a managed care organization: Aetna Better Health, Fidelis Care, Horizon NJ Health, UnitedHealthcare Community Plan, or Wellpoint.
Coverage here is unusually accessible because of deliberate state policy. Through its MATrx Model, New Jersey’s Division of Medical Assistance and Health Services removed prior authorization for buprenorphine in 2019, raised reimbursement for addiction care, and built an Office-Based Addiction Treatment program with funded Centers of Excellence and patient navigators. If you are uninsured, presumptive eligibility can let treatment begin before your application is fully processed, and many providers help you enroll.
On top of Medicaid, the access rules favor getting people into care quickly. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine for OUD, which widened where you can get it.
Additionally, federal rules updated in 2024 expanded take-home methadone up to a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth, and removed older barriers to admission. Take-home eligibility is decided by your program based on your stability.
As of June 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit. Those rules are still being finalized, so confirm current options with a provider.
Methadone for OUD remains started and dispensed through an opioid treatment program.
Staying on a steady dose is what makes long-term treatment work, and your privacy is protected. Of a job or program is involved, learn how treatment and employment fit together.
The Opioid Picture in New Jersey, and Why It Is Shifting
The trend in New Jersey is moving in the right direction. Overdose deaths among residents fell to 2,816 in 2023, down from 3,171 in 2022, with declines across every racial and ethnic group for the first time in a decade, according to the New Jersey State Unintentional Drug Overdose Reporting System (SUDORS). Preliminary 2024 data shows a further decrease.
Most of these deaths involve fentanyl, a synthetic opioid far more potent than heroin, increasingly mixed with adulterants like xylazine. State health officials credit the decline in part to wider naloxone distribution and expanded access to medication for opioid use disorder.
The numbers are still too high, and they vary by county, but they point to a clear fact for anyone reading this: Treatment works, it is available across New Jersey, and starting it is the step that changes the odds.
How to Find and Start Treatment in New Jersey
Starting usually begins with an assessment by phone, by telehealth, or in person, where a provider reviews your history and helps you choose a medication and setting.
For buprenorphine and naltrexone, that can mean an office visit and a prescription you fill the same day at a pharmacy. For methadone, you begin at an opioid treatment program.
If you are coming off fentanyl, the timing of a first buprenorphine dose matters. Starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans it with you.
The listings on this page are organized so you can find providers in your county, and many offer same-day or next-day intake. To understand the full range of outpatient and other levels of care, including when a residential or inpatient setting may be appropriate, start there, then call a provider or the helpline.
Pregnancy, Parenting, and Justice-involved Care
Some situations carry added stakes, and New Jersey has built programs around them.
For pregnant patients, methadone and buprenorphine are the recommended standard of care, and continuing medication through pregnancy is safer than stopping. NurtureNJ, the state’s initiative to make New Jersey the safest and most equitable place to give birth, and NJ FamilyCare’s Perinatal Episode of Care support coordinated maternity care, including for OUD.
Neonatal opioid withdrawal syndrome (NOWS) is manageable and expected, and a care team plans for it. And fear of losing custody should not keep anyone from treatment, since being in care is what protects both parent and baby.
For people leaving jail or prison, New Jersey works to connect them to MOUD and to enroll people in NJ FamilyCare before release so coverage is active when they get out. This is particularly important because the weeks after release carry a sharply elevated overdose risk.
Families helping a loved one can find guidance on supporting someone in treatment, and pregnant patients can read more about methadone and pregnancy.
Naloxone and Overdose Safety in New Jersey
Naloxone is the medication that reverses an opioid overdose. It is widely available in New Jersey, and it is free in many cases.
Under a statewide standing order issued after the 2021 Overdose Prevention Act expansion, you can pick up Narcan nasal spray at participating pharmacies anonymously, with no prescription and no ID, if you are 14 or older. Injectable naloxone is available by mail through the NJ Harm Reduction Coalition by calling or texting 877-4-NARCAN. The state’s network of Harm Reduction Centers, now operating in all 21 counties, distributes naloxone along with other supplies and connections to care.
New Jersey’s Good Samaritan Law protects both the person overdosing and the person who calls 911 from arrest for drug possession. If a return to use happens, it is a common and manageable part of recovery, not a failure, and having naloxone on hand is how you keep someone alive long enough to get back into care.
Common Questions About MOUD in New Jersey
Does NJ FamilyCare cover methadone and Suboxone?
Yes. NJ FamilyCare covers all three FDA-approved medications for opioid use disorder, including methadone through opioid treatment programs and buprenorphine and naltrexone through office-based providers. New Jersey removed prior authorization for buprenorphine in 2019. Coverage is delivered through managed care organizations, so check with your plan on specifics.
Do I have to go to a clinic every day for methadone?
At first, generally yes, because methadone for OUD is dispensed through an opioid treatment program. As you become stable, federal rules updated in 2024 allow take-home doses up to a 28-day supply. Your program decides take-home eligibility based on your progress in treatment.
Can I start treatment by telehealth in New Jersey?
Often, yes. As of June 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit. Methadone treatment is started through an opioid treatment program, and some programs can begin with a telehealth visit. Confirm what is current with the provider you call.
What is the difference between methadone and Suboxone?
Both treat opioid use disorder effectively. Methadone is a full opioid agonist dispensed through a clinic. Buprenorphine, the active medication in Suboxone, is a partial agonist that can be prescribed in an office and filled at a pharmacy.
Which fits you depends on your history and preferences, a choice to make with a clinician. See how dependence on these medications differs from active addiction.
What if I am starting treatment after using fentanyl?
Tell the provider, because it changes the plan. Starting buprenorphine too soon after fentanyl use can cause precipitated withdrawal, a sudden and severe withdrawal, so a clinician times your first dose and may use a specific induction approach. This is routine for providers who treat OUD and is nothing to be embarrassed about.
How long will I be in treatment?
There is no fixed answer. Many people benefit from long-term medication, and staying in treatment is associated with better outcomes than stopping early. Treatment length is something you revisit with your provider over time. Read more about how and when treatment may end.
Disclosures and References
Last reviewed June 2026.
Sources
- New Jersey Department of Health, overdose mortality data and Harm Reduction Center reporting, 2025 nj.gov/health.
- New Jersey State Unintentional Drug Overdose Reporting System (SUDORS), 2023 figures reported 2025. https://www.nj.gov/health/news/2025/approved/20250326a.shtml
- New Jersey Division of Medical Assistance and Health Services, NJ FamilyCare and MATrx Model / Office-Based Addiction Treatment program. https://www.nj.gov/humanservices/dmahs/
- New Jersey Overdose Prevention Act and Department of Health statewide naloxone standing order. https://njharmreduction.org/naloxone-access/
- NurtureNJ and NJ FamilyCare Perinatal Episode of Care. https://www.nj.gov/humanservices/dmahs/providers-stakeholders/overview/perinatalepisode.shtml
- SAMHSA and DEA, federal MOUD regulations including the 2024 revision of 42 CFR Part 8 and 2025 to 2026 buprenorphine telehealth rules. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8
- U.S. Food and Drug Administration. https://www.fda.gov/
Methadone Centers is a treatment-discovery and education resource, not a medical provider, and does not provide medical advice, diagnosis, or treatment. Information here is general and current as of the review date; confirm details with a licensed provider or your insurer.
The helpline featured on this page is a sponsored resource. Calls may be answered by a paid advertiser. Using the helpline does not obligate you to any provider, and you can also contact clinics in the listings directly.
Last Updated: July 24, 2026